1. Home
  2. EQBK vs TBPH Comparison

EQBK vs TBPH Comparison

Compare EQBK & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

HOLD

Current Price

$46.10

Market Cap

870.8M

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$19.40

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQBK
TBPH
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.8M
1.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
EQBK
TBPH
Price
$46.10
$19.40
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$50.50
$27.80
AVG Volume (30 Days)
94.6K
362.2K
Earning Date
01-21-2026
02-23-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
N/A
EPS
1.23
0.58
Revenue
$199,739,000.00
$80,327,000.00
Revenue This Year
$76.83
$70.90
Revenue Next Year
$4.61
N/A
P/E Ratio
$37.50
$33.62
Revenue Growth
N/A
27.12
52 Week Low
$34.11
$7.90
52 Week High
$50.07
$21.03

Technical Indicators

Market Signals
Indicator
EQBK
TBPH
Relative Strength Index (RSI) 45.73 49.33
Support Level $46.07 $18.45
Resistance Level $48.25 $19.71
Average True Range (ATR) 1.32 0.82
MACD -0.14 -0.10
Stochastic Oscillator 31.80 46.28

Price Performance

Historical Comparison
EQBK
TBPH

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: